The effect of 2% niacinamide on facial sebum production
- PMID: 16766489
- DOI: 10.1080/14764170600717704
The effect of 2% niacinamide on facial sebum production
Abstract
Background: The presence of sebum on the face is responsible for both facial shine and the formation of comedonal and inflammatory acne lesions. Sebum control is a goal of many OTC skin care products; however, most currently available products function by absorbing sebum from the face rather than modulating its production.
Objective: To demonstrate the effect of topical 2% niacinamide on sebum excretion rates and casual sebum production in Oriental and Caucasian populations.
Methods: Separate clinical trials were conducted in both Japan and the USA to evaluate the effect of topical 2% niacinamide in different ethnic groups. A total of 100 Japanese subjects were enrolled in a double-blind, placebo-controlled comparison between two independent balanced groups. Fifty subjects applied the 2% niacinamide moisturizer to the face for 4 weeks and 50 subjects used a placebo moisturizer for 4 weeks, with sebum excretion rate (SER) measurements taken at baseline, week 2, and week 4. In addition, 30 Caucasian subjects were enrolled in a randomized split-face study for 6 weeks with SER and casual sebum levels (CSL) measured at baseline, week 3, and week 6.
Results: The results of the Japanese study demonstrated that the SER of the two groups was not significantly different at baseline, but the 2% niacinamide treated group demonstrated significantly lowered SER after 2 and 4 weeks of application. The results were somewhat different in the Caucasian study. After 6 weeks of treatment, the CSL was significantly reduced, but the SER was not significantly reduced.
Conclusions: Topical 2% niacinamide may be effective in lowering the SER in Japanese individuals and CSL in Caucasian individuals.
Similar articles
-
The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.J Cosmet Dermatol. 2007 Dec;6(4):243-9. doi: 10.1111/j.1473-2165.2007.00342.x. J Cosmet Dermatol. 2007. PMID: 18047609 Clinical Trial.
-
Effects of a 1,450 nm diode laser on facial sebum excretion.Lasers Surg Med. 2009 Feb;41(2):110-5. doi: 10.1002/lsm.20672. Lasers Surg Med. 2009. PMID: 19226569
-
Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide.J Cosmet Dermatol. 2009 Dec;8(4):260-6. doi: 10.1111/j.1473-2165.2009.00470.x. J Cosmet Dermatol. 2009. PMID: 19958429 Clinical Trial.
-
Clinical and instrumental study of the efficacy of a new sebum control cream.J Cosmet Dermatol. 2007 Jun;6(2):113-8. doi: 10.1111/j.1473-2165.2007.00306.x. J Cosmet Dermatol. 2007. PMID: 17524128 Clinical Trial.
-
The mechanisms of action of nicotinamide and zinc in inflammatory skin disease.Cutis. 2006 Jan;77(1 Suppl):5-10. Cutis. 2006. PMID: 16871773 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
